Fasenra 30 mg in 1 mL Auto-Injector
RxNorm 2205634
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2205634 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Fasenra 30 mg in 1 mL Auto-Injector.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBDPrescribable
Semantic Branded Drug (SBD):
1 mL benralizumab 30 mg/ML Auto-Injector [Fasenra]
(Atom ID: 11456591)
SYPrescribable
Synonym (SY):
1 mL Fasenra 30 mg/ML Auto-Injector
(Atom ID: 11456593)
PSNPrescribable
Prescribable Name (PSN):
Fasenra 30 mg in 1 mL Auto-Injector
(Atom ID: 11456592)
SYPrescribable
Synonym (SY):
Fasenra 30 mg per 1 mL Auto-Injector
(Atom ID: 11456594)
Patient Education
Benralizumab Injection
Benralizumab injection is used along with other medications to prevent wheezing, difficulty breathing, chest tightness, and coughing caused by asthma in adults and children 12 years and older whose asthma is not controlled with their current asthma medication. Benralizumab injection is in a class of medications called monoclonal antibodies. It works by reducing a certain type of white blood cell to help decrease swelling and irritation of the airways to allow for easier breathing.
[Learn More]
* Please review the disclaimer below.